tailieunhanh - Medicines adherence Involving patients in decisions about prescribed medicines and supporting adherence

It is thought that between a third and a half of all medicines1 prescribed for long-term conditions are not taken as recommended. If the prescription is appropriate, then this may represent a loss to patients, the healthcare system and society. The costs are both personal and economic. Adherence presumes an agreement between prescriber and patient about the prescriber’s recommendations. Adherence to medicines is defined as the extent to which the patient’s action matches the agreed recommendations. Non-adherence may limit the benefits of medicines, resulting in lack of improvement, or deterioration, in health. The economic costs are not limited to wasted. | NHS National Institute for Health and Clinical Excellence Issue date January 2009 Medicines adherence Involving patients in decisions about prescribed medicines and supporting adherence NICE clinical guideline 76 Developed by the National Collaborating Centre for Primary Care NICE clinical guideline 76 Medicines adherence Ordering information You can download the following documents from CG76 The NICE guideline this document - all the recommendations. A quick reference guide - a summary of the recommendations for healthcare professionals. Understanding NICE guidance - a summary for patients and carers. The full guideline - all the recommendations details of how they were developed and reviews of the evidence they were based on. For printed copies of the quick reference guide or Understanding NICE guidance phone NICE publications on 0845 003 7783 or email publications@ and quote N1759 quick reference guide N1760 Understanding NICE guidance . NICE clinical guidelines are recommendations about the treatment and care of people with specific diseases and conditions in the NHS in England and Wales. This guidance represents the view of NICE which was arrived at after careful consideration of the evidence available. Healthcare professionals are expected to take it fully into account when exercising their clinical judgement. However the guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient in consultation with the patient and or guardian or carer and informed by the summary of product characteristics of any drugs they are considering. Implementation of this guidance is the responsibility of local commissioners and or providers. Commissioners and providers are reminded that it is their responsibility to implement the guidance in their local context in light of their duties to avoid unlawful discrimination and to have regard to promoting .

• Y học thường thức
• dispensing and reviewing
• healthcare professionals
• prescribed medicines
• Consumers Pay
• Systems and Farmers
• Sustainable Intensification
• International reference
• Development Goal
• Median price